chartexchange

Replimune Reports Fiscal Second Quarter 2027 Financial Results and Provides Corporate Update

GlobeNewswire Inc. | Oct 28, 2026 7:00 AM EDT

TUDRIQEV first delivered to patients for advanced melanoma on October 6th

Read original article